Radical Numerics launched with $50 million in seed funding to build multimodal AI models trained on biological data spanning DNA, RNA, and proteins. The round was led by Emergence Capital with participation from Obvious Ventures, Triatomic Capital, Factory, and First Spark Ventures. The company said its platform will reason across biological modalities to support drug target identification, cancer diagnostics, and biodefense applications. Radical Numerics also previewed a next-generation genomic language model dubbed Omnii. Backers include high-profile scientific and policy advisors, with the company naming Microsoft CSO Eric Horvitz and Harvard biologist George Church among its scientific advisors and referencing leaders from its founders’ prior generative genomics work.